38695-71-5 Usage
Uses
Used in Pharmaceutical Synthesis:
METHYL 4-PHENYLTHIOPHENE-3-CARBOXYLATE is used as a key intermediate in the synthesis of various pharmaceutical products. Its unique structure allows for the development of new molecular entities with potential therapeutic applications.
Used in Agrochemical Synthesis:
In the agrochemical industry, METHYL 4-PHENYLTHIOPHENE-3-CARBOXYLATE serves as a crucial component in the production of various agrochemicals. Its incorporation into these products enhances their effectiveness in agricultural applications.
Used in Organic Electronic Materials:
METHYL 4-PHENYLTHIOPHENE-3-CARBOXYLATE is utilized as a building block in the development of organic electronic materials. Its properties make it suitable for use in the creation of innovative materials for electronic devices and components.
Check Digit Verification of cas no
The CAS Registry Mumber 38695-71-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,6,9 and 5 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 38695-71:
(7*3)+(6*8)+(5*6)+(4*9)+(3*5)+(2*7)+(1*1)=165
165 % 10 = 5
So 38695-71-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H10O2S/c1-14-12(13)11-8-15-7-10(11)9-5-3-2-4-6-9/h2-8H,1H3
38695-71-5Relevant academic research and scientific papers
Catalyst-Controlled Regiodivergent Dehydrogenative Heck Reaction of 4-Arylthiophene/Furan-3-Carboxylates
Gao, Shang,Wu, Zijun,Wu, Fei,Lin, Aijun,Yao, Hequan
supporting information, p. 4129 - 4135 (2016/12/30)
A catalyst-controlled regiodivergent dehydrogenative Heck reaction of 4-arylthiophene/furan-3-carboxylates has been realized. Use of a palladium catalyst led to the C-5 alkenylation through electronic palladation, while a ruthenium catalyst favored the C-2 alkenylation with the assistance of a directing group. This reaction exhibited good to excellent regioselectivities. (Figure presented.).
Novel quinuclidinyl heteroarylcarbamate derivatives as muscarinic receptor antagonists
Nagashima, Shinya,Matsushima, Yuji,Hamaguchi, Hisao,Nagata, Hiroshi,Kontani, Toru,Moritomo, Ayako,Koshika, Tadatsura,Takeuchi, Makoto
, p. 3478 - 3487 (2014/06/23)
Herein, we describe the synthesis and pharmacological profiles of novel quinuclidinyl heteroarylcarbamate derivatives. Among them, the quinuclidin-4-yl thiazolylcarbamate derivative ASP9133 was identified as a promising long-acting muscarinic antagonist (LAMA) showing more selective inhibition of bronchoconstriction against salivation and more rapid onset of action in a rat model than tiotropium bromide.
